medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-04-28 匿名用户

平行投稿容易被发现

201 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-07-16 匿名用户

平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现

152 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-08-23 ms6000001672735995 来自湖北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：中医;综述
经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。

130 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-10-03 lzh 来自北京

审稿速度:12.0 | 投稿命中率:50.0
经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗

196 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-10-20 jarm190 来自安徽省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：免疫;临床研究
经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。

119 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-12-20 ms9000000273547413

偏重的研究方向：医工结合;大语言模型
经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？

159 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-02-19 文体两开花来自四川省

审稿速度:6.0
经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了

119 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-05-10 ms4000001373859908 来自广东省

最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了

134 21 举报

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-11-06 neural 来自云南省

纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process

78 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2262586, encodeId=727d226258699, content=平行投稿容易被发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Apr 28 11:00:46 CST 2025, time=2025-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273596, encodeId=55eb22e3596f3, content=平行投稿同时投JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 被medicine发现, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Jul 16 13:12:57 CST 2025, time=2025-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2278387, encodeId=8e0422e838733, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中医;综述 经验分享：投稿第二天with editor,第五天变成under review,目前状态26天了，还没更新，也不知道咋样，希望赶紧有消息，改了好录用吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1c7b9547969, createdName=ms6000001672735995, createdTime=Sat Aug 23 15:54:05 CST 2025, time=2025-08-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2283586, encodeId=13e1228358633, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：杂志给我的意见是OA accept pending minor revision，返修后with editor状态两个月，没有送外审，今天直接Decision in Process是要被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ECCfxRwHxC4LgVlQicfaC6Q1X42fzqwfIhDu9gaibicpHDuzCUz0lNtYBic6HEL7LfnUB683wOQBUcyLZ1lM8BKcgA/132, createdBy=caae5322593, createdName=lzh, createdTime=Fri Oct 03 21:18:39 CST 2025, time=2025-10-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2285478, encodeId=e4b122854e8b6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫;临床研究 经验分享：7.25投稿，9.15初审决定修改，10.6修回，10.15接受，总体挺快的，不拖沓。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=599895997, createdName=jarm190, createdTime=Mon Oct 20 20:23:11 CST 2025, time=2025-10-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2293988, encodeId=9aa52293988bb, content=偏重的研究方向：医工结合;大语言模型 经验分享：大佬们最近人工AI与医学结合的临床研究审稿速度如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e1e9541662, createdName=ms9000000273547413, createdTime=Sat Dec 20 13:47:56 CST 2025, time=2025-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2252651, encodeId=620922526517a, content=审稿速度:6.0 经验分享：去年8月底至今快6个月了，依然是under review，太磨蹭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1489469709, createdName=文体两开花, createdTime=Wed Feb 19 16:39:34 CST 2025, time=2025-02-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264386, encodeId=97ce2264386c0, content=最近有人接收了吗？we加审稿3个月，返修后整整3个月现在还在we，半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce6584759, createdName=ms4000001373859908, createdTime=Sat May 10 20:14:53 CST 2025, time=2025-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2287818, encodeId=3ad2228e818e0, content=纯生信文章，去年11月底投稿，中间经历漫长的under review，2位审稿人给出返修意见，马山就快一年了，第二次返修一月后出现decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/11/2d6f0e441c61f8d460a6e1fbf3147562.jpg, createdBy=2fde5142589, createdName=neural, createdTime=Thu Nov 06 14:28:05 CST 2025, time=2025-11-06, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2287099, encodeId=5f7b228e09985, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胰岛素抵抗;心血管病 经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=653c8642916, createdName=ms4000000495559800, createdTime=Sat Nov 01 13:28:17 CST 2025, time=2025-11-01, status=1, ipAttribution=河北省)]

2025-11-01 ms4000000495559800 来自河北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：胰岛素抵抗;心血管病
经验分享：同时投了3篇，分别1天后under、2天后under，4天后under，这个杂志投稿都送外审吗？

70 4 举报

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务